New drug cocktail shows promise against Tough-to-Treat skin cancer
NCT ID NCT04640545
Summary
This early-stage trial tested the safety and initial effectiveness of a three-drug combination for people with advanced melanoma that cannot be removed by surgery. The study involved 79 participants and aimed to find the safest dose and see if the drugs could help control the cancer. The treatment combined an experimental drug (LBL-007) with two existing cancer drugs (toripalimab and axitinib).
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
-
Fujian Cancer Hospital
Fuzhou, Fujian, 350000, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410006, China
-
Jilin Cancer Hospital
Changchun, Jilin, 130021, China
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210008, China
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, 430022, China
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
-
the First Hospital of Jilin University
Changchun, Jilin, 130021, China
Conditions
Explore the condition pages connected to this study.